The Recall Desk
ModerateFDA (Devices)·Z-2088-2026·Announced 2026-05-13

One Step P in vitro diagnostic test lacks FDA premarket clearance

The One Step P in vitro diagnostic test (REF 8194) was distributed without required FDA premarket clearance or approval. The manufacturer DFI Co., Ltd. is recalling the device.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The device was distributed without FDA premarket clearance, which is a regulatory violation. The source text does not report any adverse health consequences, deaths, injuries, or hospitalizations. As a Class II recall with a regulatory rather than safety-hazard basis and no reported harm, this meets the Moderate threshold.

Plain-English summary

DFI Co., Ltd. is recalling the One Step P in vitro diagnostic test (REF 8194) because the devices were distributed without required FDA premarket clearance or approval.

The affected product was distributed nationwide in Florida and Pennsylvania, as well as in England. A total of 1064 units were affected, with lot numbers 241023, 250527, and 250905. The device's UDI is 08806141302025.

Consumers and healthcare providers in possession of this device should stop using it and contact DFI Co., Ltd. for instructions on return or disposal.

The recalled product

Product
One Step P in vitro diagnostic test REF: 8194
Manufacturer
DFI Co., Ltd.
Hazard
  • unapproved-distribution
  • regulatory-violation

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • UDI:08806141302025/ Lot: 241023
  • 250527
  • 250905

Distribution

Distributed nationwide across the United States.